Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Transl Issues Psychol Sci. 2021 Feb 4;7(2):141–153. doi: 10.1037/tps0000250

Figure 1. Percentage of Participants in Outpatient MOUD with Buprenorphine who Reported Discrimination in Healthcare Setting within Past 12 Months, by Gender.

Figure 1.

Note. Responses to the question “In the past 12 months, have you ever felt you were treated unfairly in getting healthcare services because of any of the following?”

MOUD, medication treatment for opioid use disorder

* “Any discrimination” includes participants who reported discrimination in ≥1 category.